NCT02600026

Brief Summary

This study will use an in-car monitoring system supplemented with video feedback to reduce the number of unsafe driving behaviors. If successful, this technology will provide a means to enhance public safety on the roads that could be adopted immediately in this at-risk group of drivers. The intervention will also maximize the time for independent driving, improving the overall quality of life of these individuals.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Nov 2015

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

November 5, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 9, 2015

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
Last Updated

May 15, 2018

Status Verified

May 1, 2018

Enrollment Period

3.6 years

First QC Date

November 5, 2015

Last Update Submit

May 9, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of unsafe driving events

    Unsafe events rated as \> 5 points using a modification of standard scale developed by Drivecam monitoring video service. This includes incidents, near-crashes, and crashes, sub classified as being triggered by hard turns, severe braking, and/or impact, adjusted for miles driven.

    9 months

Secondary Outcomes (2)

  • Severity score of unsafe driving events

    9 months

  • Time to driving cessation

    1-2 years

Study Arms (2)

Video Camera: Intervention

EXPERIMENTAL

DriveCam video event recorder with feedback

Device: DriveCamBehavioral: Feedback

Video Camera: Monitoring

PLACEBO COMPARATOR

DriveCam video event recorder with no feedback

Device: DriveCam

Interventions

DriveCamDEVICE

Video event monitoring device

Video Camera: InterventionVideo Camera: Monitoring
FeedbackBEHAVIORAL

Video feedback intervention

Video Camera: Intervention

Eligibility Criteria

Age50 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 50-90
  • will be categorized as CDR= 0.5, or 1
  • English speaking
  • currently driving adults
  • have a valid driving license
  • have at least 10 years of driving experience
  • have a MMSE \< 28
  • have an adult family member or other caregiver, age \>21, to participate in video feedback

You may not qualify if:

  • ophthalmologic, physical, or neurologic disorders other than dementia that impair their driving abilities
  • visual acuity worse than 20/40 in best eye using distance vision measured by wall chart
  • homonymous hemianopia or bitemporal hemianopia
  • musculoskeletal disorders causing major physical handicaps
  • history of alcohol or substance abuse by DSM V criteria within the past year
  • sedating medications that impair level of consciousness or attention
  • language impairment that would interfere with the ability to participate in the educational intervention
  • previous road test evaluation or opinion of caregiver or health professional that participant is unsafe to drive.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rhode Island Hospital

Providence, Rhode Island, 02903, United States

RECRUITING

Study Officials

  • Brian Ott, MD

    Rhode Island Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gauri Vasudevan, B.S.

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Brian R. Ott, MD

Study Record Dates

First Submitted

November 5, 2015

First Posted

November 9, 2015

Study Start

November 1, 2015

Primary Completion

June 1, 2019

Study Completion

June 1, 2019

Last Updated

May 15, 2018

Record last verified: 2018-05

Locations